Skip to main content
Equibles

FMR LLC

Position in VCEL — Vericel Corp

CIK 315066 BOSTON, MA
Back to VCEL Full portfolio

Position in VCEL

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$2,801,134
+$32,168 QoQ
Shares Held
62,961
-26.9% QoQ
Ownership
0.123%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#92
of 317 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in VCEL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

FMR LLC holds $61,908,415,112 across 370 Biotechnology names. VCEL ranks #189 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 5,231,452 $4,853,584,218
2 ALNY
Alnylam Pharmaceuticals, Inc.
 15,023,962 $4,522,663,276
3 MRNA
Moderna, Inc.
 51,859,891 $3,631,748,165
4 ROIV
Roivant Sciences Ltd.
 81,020,390 $2,867,311,601
5 RVMD
Revolution Medicines, Inc.
 12,200,422 $2,284,895,029
6 IONS
Ionis Pharmaceuticals Inc
 24,631,956 $1,953,067,789
7 INSM
INSMED Inc
 16,143,583 $1,721,228,815
8 KRYS
Krystal Biotech, Inc.
 4,418,197 $1,642,111,277

All Filings in VCEL

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,801,134 62,961
2026-03-31 $2,768,966 86,073
2025-12-31 $78,249,188 2,172,985
2025-09-30 $63,502,619 2,017,878
2025-06-30 $105,276,315 2,474,179
2025-03-31 $102,620,777 2,299,883
2024-12-31 $117,231,476 2,134,975
2024-09-30 $100,251,306 2,372,812
2024-06-30 $107,834,102 2,350,351
2024-03-31 $109,688,643 2,108,586
2023-12-31 $21,047,895 591,067
2023-09-30 $19,149,908 571,298
2023-06-30 $15,390,400 409,646
2023-03-31 $11,861,258 404,545
2022-12-31 $9,962,445 378,225
2022-09-30 $8,640,956 372,455
2022-06-30 $9,412,182 373,796
2022-03-31 $14,127,449 369,635
2021-12-31 $13,947,845 354,907
2021-09-30 $17,460,200 357,791
2021-06-30 $18,653,722 355,309
2021-03-31 $30,451,509 548,182
2020-12-31 $15,065,702 487,879
2020-09-30 $9,950 537
2020-06-30 $7,310 529